← Leaderboards
Joseph B. Ciolino
Massachusetts Eye And Ear Infirmary
$8,244,054
Attributed
$8,244,054
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.9M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,244,054 · 6
By mechanism
R01$5,682,602 · 3
UG3$1,120,889 · 1
K08$1,092,917 · 1
UH3$347,646 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Eye And Ear Infirmary
Same institution · by research overlap
- Pedram Hamrah$15,767,152
- Bruce R Ksander$8,642,324
Others in their field
Top investigators on “Cornea”
- Raymond Kraker · Jaeb Center For Health Research, Inc.$47,584,981
- Ehud Isacoff · University Of California Berkeley$23,946,000
- Mary Ann Stepp · George Washington University$18,098,163
- Keri Hammel · The Emmes Company, Llc$17,992,237
- Reza Dana · Schepens Eye Research Institute$17,808,908
- Eric Pearlman · Case Western Reserve University$16,337,424
Research focus
CorneaIn VitroIn VivoOryctolagus CuniculusTissuesEyedropsPharmaceutical PreparationsSafetyInterestCorneal Epithelial Wound HealingGenerationsFilmCorneal ScarGlaucomaMedicalPolymersBiomaterial CompatibilityBlindnessContact LensesDrug Delivery SystemsDropsAnti-Bacterial AgentsCorneal InjuryHealing
Grant awards (20)
Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis$523,874
R01 · FY2025 · EY · contact PI
Anesthetic-Eluting Contact Lens for Corneal Pain$347,646
UH3 · FY2025 · NS · contact PI
Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis$616,322
R01 · FY2024 · EY · contact PI
VRC Inhibiting p38 to Prevent and Restore Corneal Scarring$261,431
R01 · FY2024 · EY · contact PI
Anesthetic-Eluting Contact Lens for Corneal Pain$1,120,889
UG3 · FY2023 · NS · contact PI
Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis$524,717
R01 · FY2023 · EY · contact PI
VRC Inhibiting p38 to Prevent and Restore Corneal Scarring$250,771
R01 · FY2023 · EY · contact PI
Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis$524,717
R01 · FY2022 · EY · contact PI
Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis$477,725
R01 · FY2021 · EY · contact PI
Corneal Epithelial-Stromal Interactions During Regeneration and Fibrosis$492,500
R01 · FY2020 · EY · contact PI
Antibiotic eluting contact lenses for the treatment of bacterial keratitis$488,559
R01 · FY2020 · EY · contact PI
Antibiotic eluting contact lenses for the treatment of bacterial keratitis$488,660
R01 · FY2019 · EY · contact PI
Antibiotic eluting contact lenses for the treatment of bacterial keratitis$492,054
R01 · FY2018 · EY · contact PI
Antibiotic eluting contact lenses for the treatment of bacterial keratitis$38,900
R01 · FY2018 · EY · contact PI
Antibiotic eluting contact lenses for the treatment of bacterial keratitis$502,372
R01 · FY2017 · EY · contact PI
Drug Eluting Contact Lenses$230,028
K08 · FY2013 · EY · contact PI
Drug Eluting Contact Lenses$224,114
K08 · FY2012 · EY · contact PI
Drug Eluting Contact Lenses$218,373
K08 · FY2011 · EY · contact PI
Drug Eluting Contact Lenses$212,799
K08 · FY2010 · EY · contact PI
Drug Eluting Contact Lenses$207,603
K08 · FY2009 · EY · contact PI